![Namandje Bumpus](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermögen: 154 984 $ am 31.05.2026
Namandje N.
Bumpus is an Independent Director at Recursion Pharmaceuticals, Inc. since 2025, Senior VP, Chief Innovation & Scientific Officer at Charles River Laboratories International, Inc. since 2026, and Venture Partner at F-Prime, Inc. since 2025.
Former roles include Director at AI Proteins, Inc. and Professor at The Johns Hopkins University School of Medicine from 2020 to 2022.
Education includes an undergraduate degree from Occidental College in 2003 and a doctorate from the University of Michigan in 2007.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 03.06.2026 | 43’171 ( 0.01% ) | 154 984 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| RECURSION PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 15.03.2025 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Technik-/Wissenschafts-/F&E-Leiter | 12.01.2026 |
Impresa Management LLC
 Impresa Management LLC Investment ManagersFinance F-Prime invests in companies located in Asia, Europe, North America, and South America. The firm targets companies operating in life sciences, technology, healthtech & services and crypto sectors. It provides financing for seed, early and later stage transactions. | Private Equity Investor | 01.05.2025 |
| Unternehmen | Position | Ende |
|---|---|---|
The Johns Hopkins University School of Medicine
 The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.01.2022 |
AI Proteins, Inc.
 AI Proteins, Inc. Packaged SoftwareTechnology Services Develops AI powered protein therapeutics discovery platform | Direktor/Vorstandsmitglied | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 7 |
|---|---|
Charles River Laboratories International, Inc.
 Charles River Laboratories International, Inc. Miscellaneous Commercial ServicesCommercial Services Provides laboratory testing and research services on a contract basis | Commercial Services |
Recursion Pharmaceuticals, Inc.
 Recursion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that combines biology, chemistry, automation, data science and engineering to industrialize drug discovery | Health Technology |
Occidental College
 Occidental College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University School of Medicine
The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Impresa Management LLC
Impresa Management LLC Investment ManagersFinance F-Prime invests in companies located in Asia, Europe, North America, and South America. The firm targets companies operating in life sciences, technology, healthtech & services and crypto sectors. It provides financing for seed, early and later stage transactions. | Finance |
AI Proteins, Inc.
AI Proteins, Inc. Packaged SoftwareTechnology Services Develops AI powered protein therapeutics discovery platform | Technology Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
